Both Medicines Australia and Anne Single have declined to respond to questions on whether they opposed what effectively acts as an exclusion criteria for the responses provided by the organisations and people they purport to represent.
Previous public statements about HTA policies and outcomes are considered a conflict
February 21, 2024 Latest NewsBioPharmaNews of the Day
Latest Video
New Stories
-
The effort to change an institution from within, works best when exit is possible
October 15, 2026 - - Latest News -
The medicines gap costing Australian children time they can't get back
October 15, 2026 - - Latest News -
Brain cancer advocates return to Canberra 'to keep that ambition alive'
October 15, 2026 - - Latest News -
Priceline Pharmacy puts its name on the Diamonds as netball rides record growth
October 14, 2026 - - Latest News -
Until the law changes what the committee is instructed to weigh, these processes will deliver nothing
October 14, 2026 - - Latest News -
'Maximising off patent medicines and why the PBS needs a biosimilar strategy'
October 14, 2026 - - Latest News -
Peter Mac taps Sydney manufacturer to test its solid tumour CAR T therapy
October 14, 2026 - - Latest News
